The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announce that the U.S. Food and Drug Administration (FDA) has accepted for priority ...

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...

With an expiration date still more than a year away, here's what the latest details reveal.

An ADHD diagnosis means a person is prone to impulsivity and distractibility, which can manifest in the form of substance misuse, traffic accidents, criminality and even suicidal behavior. A recent ...

Scientists are updating their view of how drugs like Adderall and Ritalin help children with attention deficit hyperactivity disorder stay on task. The latest evidence is a study of thousands of brain ...

Scientists are changing their view of how drugs like Adderall and Ritalin help children with ADHD stay on task. NPR's Jon Hamilton reports on a new study that found the drugs act on brain networks ...

New brain research could reshape our understanding of ADHD and the most common drugs that treat it.